The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of IO-TKI vs IO-IO combinations in IMDC poor-risk metastatic renal cell carcinoma (mRCC) patients (Meet-URO 33 analysis).
 
Sara Elena Rebuzzi
No Relationships to Disclose
 
Alessio Signori
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Speakers' Bureau - Astellas Pharma; BMS; Ipsen; Merck; Merck/Pfizer; MSD; Pfizer
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Alberto Dalla Volta
No Relationships to Disclose
 
Martina Fanelli
No Relationships to Disclose
 
Valeria Sardaro
No Relationships to Disclose
 
Marilena Di Napoli
No Relationships to Disclose
 
Cristina Masini
No Relationships to Disclose
 
Annalisa Guida
No Relationships to Disclose
 
Roberto Filippi
No Relationships to Disclose
 
Silvia Chiellino
No Relationships to Disclose
 
Carlo Messina
No Relationships to Disclose
 
Sarah Scagliarini
No Relationships to Disclose
 
Emanuela Fantinel
No Relationships to Disclose
 
Lucia Bonomi
No Relationships to Disclose
 
Vincenza Conteduca
No Relationships to Disclose
 
Filippo Maria Deppieri
No Relationships to Disclose
 
Mariella Sorarù
No Relationships to Disclose
 
Giuseppe Fornarini
No Relationships to Disclose
 
Davide Bimbatti
No Relationships to Disclose
 
Meet-URO (Italian Network For Research In Urologic-Oncology)
No Relationships to Disclose